Identifying high-risk colon cancer on CT an a radiomics signature improve radiologist’s performance for T staging?
Authors:
- 4 June 2022
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 47 (8) , 2739-2746
Abstract
Purpose To assess the role of radiomics in detection of high-risk (pT3-4) colon cancer and develop a combined model that combines both radiomics and CT staging of colon cancer. Methods We included 292 colon cancer patients who underwent pre-operative CT and primary surgical resection within 2 months. Three-dimensional segmentations and CT staging of primary colon tumors were done. From each 3D segmentation of colon tumor, radiomic features were automatically extracted. Logistic regression analysis was performed to identify associations between radiomic features and high-risk (pT3-4) colon tumors. A combined model that integrated both radiomics and CT staging was developed and their diagnostic performance was compared with that of conventional CT staging. Tenfold cross-validation was used to validate the performance of the model and CT staging. Results The model that combined radiomic features and CT staging demonstrated a significantly better performance in detection of high-risk colon tumors in training set (AUC = 0.799, 95% CI: 0.720–0.839 for combined model and AUC = 0.697, 95% CI = 0.538–0.756 for CT staging only, p < 0.001 for difference). Cross-validation results also demonstrated significantly better detection performance of combined model (AUC = 0.727, 95% Confidence Interval (CI): 0.621–0.777 for combined model and AUC = 0.628, 95% CI = 0.558–0.689 for CT staging only, Boot CI = 0.099). Conclusion CT radiomic features of primary colon cancer, combined with CT staging, can improve the detection of high-risk colon cancer patients.Keywords
This publication has 22 references indexed in Scilit:
- Short-term reproducibility of radiomic features in liver parenchyma and liver malignancies on contrast-enhanced CT imagingAbdominal Radiology, 2018
- Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?European Radiology, 2018
- CT and 3-T MRI accurately identify T3c disease in colon cancer, which strongly predicts disease-free survivalClinical Radiology, 2017
- Diagnostic Accuracy of CT for Local Staging of Colon Cancer: A Systematic Review and Meta-AnalysisAmerican Journal of Roentgenology, 2016
- Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal CancerJournal of Clinical Oncology, 2016
- Measuring Computed Tomography Scanner Variability of Radiomics FeaturesInvestigative Radiology, 2015
- Neoadjuvant chemotherapy in locally advanced colon cancer.A phase II trialActa Oncologica, 2015
- Tumor response assessment in locally advanced colon cancer after neoadjuvant chemotherapy2014
- Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trialThe Lancet Oncology, 2012
- Accuracy of radiological staging in identifying high‐risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experienceColorectal Disease, 2011